Business Description
Apogee Therapeutics Inc
NAICS : 541714
SIC : 2833
ISIN : US03770N1019
Description
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 43.33 | |||||
| Equity-to-Asset | 0.95 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.07 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Future 3-5Y EPS without NRI Growth Rate | -18.91 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.8 | |||||
| 9-Day RSI | 50.71 | |||||
| 14-Day RSI | 48.81 | |||||
| 6-1 Month Momentum % | 14.37 | |||||
| 12-1 Month Momentum % | 55.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 16.39 | |||||
| Quick Ratio | 16.39 | |||||
| Cash Ratio | 16.13 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -16.57 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -21.13 | |||||
| ROA % | -22.71 | |||||
| ROIC % | -228.92 | |||||
| ROC (Joel Greenblatt) % | -2851.08 | |||||
| ROCE % | -27.17 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 3.68 | |||||
| Price-to-Tangible-Book | 3.68 | |||||
| EV-to-EBIT | -13.01 | |||||
| EV-to-EBITDA | -13.02 | |||||
| EV-to-FCF | -16.38 | |||||
| Price-to-Net-Current-Asset-Value | 5.39 | |||||
| Price-to-Net-Cash | 5.48 | |||||
| Earnings Yield (Greenblatt) % | -7.69 | |||||
| FCF Yield % | -4.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:APGE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Apogee Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.754 | ||
| Beta | 0 | ||
| Volatility % | 110.11 | ||
| 14-Day RSI | 48.81 | ||
| 14-Day ATR ($) | 3.478997 | ||
| 20-Day SMA ($) | 46.8235 | ||
| 12-1 Month Momentum % | 55.16 | ||
| 52-Week Range ($) | 27.05 - 72.29 | ||
| Shares Outstanding (Mil) | 56.9 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Apogee Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Apogee Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Apogee Therapeutics Inc Frequently Asked Questions
What is Apogee Therapeutics Inc(APGE)'s stock price today?
The current price of APGE is $46.72. The 52 week high of APGE is $72.29 and 52 week low is $27.05.
When is next earnings date of Apogee Therapeutics Inc(APGE)?
The next earnings date of Apogee Therapeutics Inc(APGE) is 2025-03-05 Est..
Does Apogee Therapeutics Inc(APGE) pay dividends? If so, how much?
Apogee Therapeutics Inc(APGE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers